David Altarac

Directeur Médical

US·SEC (Form 4)

Entasis Therapeutics Holdings Inc.

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 11 Jul 2022 for Entasis Therapeutics Holdings Inc., €38k. Read the official filing

Insider track record

Disclosed buys

Disclosed sells

Signal history

David Altarac: trading record in brief

David Altarac (senior executive) discloses dealings in Entasis Therapeutics Holdings Inc. to SEC (Form 4). In total, 4 filings cover trades dated from 19 October 2021 to 7 July 2022.

The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

Most recently, on 11 July 2022, the filings show a transaction worth €38k in Entasis Therapeutics Holdings Inc. Typically, a trade is published a median of 1 day after it takes place. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.